Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
AKYAAkoya Biosciences(AKYA) Newsfilter·2024-03-05 05:05

Q4 2023 revenue 26.5millionandFY2023revenue26.5 million and FY 2023 revenue 96.6 million Guiding FY 2024 revenue range $114.0-118.0 million and operating cash flow breakeven by YE 2024 MARLBOROUGH, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (NASDAQ:AKYA) ("Akoya"), The Spatial Biology Company®, today announced its financial results for the fourth quarter and full year ending December 31, 2023. "Akoya's successful 2023 performance reflects the high demand for our leading spatial biology solutions and effective ...